Skip to content

Drug interactions

Aprepitant + Ivosidenib

Severity: Moderate

Aprepitant and Ivosidenib: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Ivosidenib induces CYP3A4 and may lower aprepitant concentrations. This may reduce antiemetic protection against chemotherapy-induced nausea and vomiting.

What this interaction means in plain words

Aprepitant and Ivosidenib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Aprepitant belongs to Gastrointestinal Tract; Ivosidenib belongs to Oncology.

Evidence level: Moderate

Why it happens

Ivosidenib induces CYP3A4, increasing aprepitant clearance.

What to do

Monitor for breakthrough nausea and vomiting and add or switch antiemetics if control is inadequate. Ivosidenib exposure may rise with aprepitant, so monitor for QTc prolongation and differentiation syndrome.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Aprepitant and Ivosidenib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Aprepitant with Ivosidenib?

MediHelp rates the interaction as moderate. Aprepitant and Ivosidenib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Ivosidenib induces CYP3A4 and may lower aprepitant concentrations. This may reduce antiemetic protection against chemotherapy-induced nausea and vomiting.

How serious is the interaction between Aprepitant and Ivosidenib?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for breakthrough nausea and vomiting and add or switch antiemetics if control is inadequate. Ivosidenib exposure may rise with aprepitant, so monitor for QTc prolongation and differentiation syndrome.

What other medicines interact with Aprepitant?

MediHelp also lists interactions of Aprepitant with, for example, Lomitapide, Pimozide, Avapritinib. The full list is on the Aprepitant page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in